sulfasalazine has been researched along with Papulosquamous Disorders in 2 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Greef, E | 1 |
| Mennie, K | 1 |
| Muise, A | 1 |
| Shimazaki, J | 1 |
| Yang, HY | 1 |
| Shimmura, S | 1 |
| Tsubota, K | 1 |
2 other studies available for sulfasalazine and Papulosquamous Disorders
| Article | Year |
|---|---|
Drug reaction with eosinophilia and systemic symptoms.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; C-Reactive Protein; Eosinophilia; Fever; Humans | 2010 |
Terrien's marginal degeneration associated with erythema elevatum diutinum.
Topics: Adult; Chronic Disease; Colchicine; Conjunctiva; Conjunctival Diseases; Cornea; Corneal Ulcer; Drug | 1998 |